Allogene Therapeutics (ALLO) Non Operating Interest Expenses (2018 - 2026)
Allogene Therapeutics' Non Operating Interest Expenses was $343,000 in Q2 2026, up 28.0% from $268,000 a year earlier and up 14.3% from the prior quarter.
Powered by 
Analysis
Allogene Therapeutics (ALLO) Non Operating Interest Expenses (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Allogene Therapeutics' Non Operating Interest Expenses was $1.3 million through Jun 30, 2026, up 117.0% year-over-year; for FY2025, it was $1.08 million, up 493.9% from FY2024.
- In earlier years, Non Operating Interest Expenses was $181,000 in FY2024.
- Quarterly Non Operating Interest Expenses has moved between $81,000 (Q4 2024) and $344,000 (Q3 2025) over five years.
- Compared with a year earlier, Non Operating Interest Expenses has increased for four straight quarters, with growth averaging 164.6% over the last four quarters.
- Per Business Quant data, ALLO's Non Operating Interest Expenses in the three quarters before Q2 2026 was $300,000 (Q1 2026), $313,000 (Q4 2025) and $344,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Allogene Therapeutics | 552.55 Mn | 552.55 Mn | - | 343,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 343,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 313,000.00 |
| Sep 30, 2025 | 344,000.00 |
| Jun 30, 2025 | 268,000.00 |
| Mar 31, 2025 | 150,000.00 |
| Dec 31, 2024 | 81,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2018 | 3.36 Mn |
API Access
Allogene Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ALLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "ALLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ALLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();